在一个患有严重泛性性牛皮的4个月大婴儿中成功治疗sequukinumab:一个病例报告
Long Wang1, Yirong Li2, Chen Li2
1Department of Dermatology and Venereology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Frontiers in medicine
|December 1, 2025
概括
在一个4个月大的婴儿中,secukinumab有效地治疗了泛性性牛皮 (GPP),实现了完全的皮肤清除. 复发是通过再给药来管理的,这表明GPP对幼儿的潜在益处.
科学领域:
- 皮肤病学 皮肤病学
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
背景情况:
- 泛性性牛皮 (GPP) 是一种罕见的,严重的皮肤疾病.
- 有限的数据存在于secukinumab在儿科GPP的使用,特别是在婴儿.
- 用secukinumab治疗斑块性牛皮已经确立,但GPP反应的理解较少.
研究的目的:
- 报告secukinumab在患有泛性性牛皮 (GPP) 的婴儿中的疗效和安全性.
- 评估secukinumab作为严重儿科GPP的治疗选择.
- 在具有挑战性的儿科皮肤病中为secuquinumab提供临床证据.
主要方法:
- 一个4个月大的婴儿被诊断患有中度至重度GPP的案例研究.
- 治疗包括每周注射sequinumab (50毫克) 和每天使用软化剂.
- 在一年内监测临床反应和复发情况.
主要成果:
- 在四次secukinumab注射后,GPP病变的完全消失得到了实现.
- 在治疗停止一年后,婴儿出现了复发.
- 在一次性重新注射sequukinumab后,观察到几乎完全的解决.
结论:
- 在患有GPP的婴儿中,secukinumab显示出显著的临床益处和可接受的安全概况.
- 需要进一步的研究来确定最佳剂量和长期安全性.
- 塞库金纽马布作为幼儿GPP的治疗选择具有前景.
相关概念视频
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...